Compare BSX & ICE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSX | ICE |
|---|---|---|
| Founded | 1979 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.4B | 93.2B |
| IPO Year | 2010 | 2013 |
| Metric | BSX | ICE |
|---|---|---|
| Price | $64.46 | $160.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 21 | 9 |
| Target Price | $102.10 | ★ $194.78 |
| AVG Volume (30 Days) | ★ 14.5M | 2.6M |
| Earning Date | 04-22-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.27% |
| EPS Growth | ★ 55.20 | 20.71 |
| EPS | 1.94 | ★ 5.77 |
| Revenue | ★ $9,076,000,000.00 | $5,834,000,000.00 |
| Revenue This Year | $11.85 | $10.29 |
| Revenue Next Year | $10.16 | $4.76 |
| P/E Ratio | $32.70 | ★ $28.36 |
| Revenue Growth | ★ 12.49 | N/A |
| 52 Week Low | $60.59 | $143.17 |
| 52 Week High | $109.50 | $189.35 |
| Indicator | BSX | ICE |
|---|---|---|
| Relative Strength Index (RSI) | 42.88 | 49.44 |
| Support Level | $60.59 | $158.61 |
| Resistance Level | $76.77 | $162.48 |
| Average True Range (ATR) | 1.78 | 3.84 |
| MACD | 0.56 | 0.21 |
| Stochastic Oscillator | 75.10 | 51.10 |
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Intercontinental Exchange is a vertically integrated operator of financial exchanges and provides ancillary data products. Though the company is probably best known for its ownership of the New York Stock Exchange, which it acquired in 2013, ICE operates a large derivatives exchange, too. The company's largest commodity futures product is the ICE Brent crude futures contract. In addition to the exchanges business, which is about 54% of net revenue, Intercontinental Exchange has used a series of acquisitions to create its mortgage technology business (22% of net revenue) and fixed-income and data services segment (24% of net revenue).